The 5-Second Trick For DO-264
The 5-Second Trick For DO-264
Blog Article
quinupristin/dalfopristin will increase the degree or result of estrogens conjugated synthetic by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
quinupristin/dalfopristin will boost the degree or impact of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug.
quinupristin/dalfopristin will enhance the level or outcome of buspirone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
quinupristin/dalfopristin will lower the level or influence of bazedoxifene/conjugated estrogens by altering intestinal flora. Applies only to oral varieties of hormone. Low danger of contraceptive failure. Use Warning/Keep track of.
quinupristin/dalfopristin will boost the stage or effect of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
quinupristin/dalfopristin will improve the stage or result of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
quinupristin/dalfopristin will increase the stage or impact of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
quinupristin/dalfopristin will improve the stage or impact of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
quinupristin/dalfopristin will enhance the stage or result of temsirolimus by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Insignificant (one)quinupristin/dalfopristin will improve the stage or impact of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.
quinupristin/dalfopristin will increase the stage or outcome of conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
quinupristin/dalfopristin will enhance the level or impact of repotrectinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Discontinue strong or moderate CYP3A inhibitors MU1656 and wait around 3-5 elimination half-lives prior to initiating repotrectinib.
Watch Intently (1)quinupristin/dalfopristin will minimize the level or effect of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Use of a CYP3A4 inhibitor might minimize metabolism of ifosfamide, perhaps reducing ifosfamide therapeutic outcomes.
quinupristin/dalfopristin will raise the amount or outcome of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.